Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine for Osteoarthritis Knee Pain
NCT00945945Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jul 2009
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 8
01
Overview
Phase 3, randomised, double-blind trial of duloxetine in osteoarthritis (OA) (2 arms), sponsored by Eli Lilly and Company. Primary endpoint: Brief Pain Inventory 24-Hour Average Pain Item (Question 3) at 13 weeks. Started Jul 2009; status: completed.
02
Drugs
duloxetine
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00945945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00945945.